Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 274,327 |
|
|||||
| News | - | ||||||
| Day High | 0.749899 | Low High |
|||||
| Day Low | 0.7151 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0478 | 6.62% | 0.77 | 19:59:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.72 | 0.7151 | 0.749899 | 0.722 | 0.7222 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 635 | 274,327 | $ 0.7269089 | $ 199,411 | - | 0.593 - 1.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:58 | formt | 100 | $ 0.77 | USD |
Cidara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 65.11M | 90.43M | - | 64.29M | -29.8M | -0.33 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cidara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.93 | 0.9599 | 0.69 | 0.7755061 | 610,962 | -0.16 | -17.20% |
| 1 Month | 0.78 | 1.22 | 0.69 | 0.9461174 | 1,122,800 | -0.01 | -1.28% |
| 3 Months | 0.6715 | 1.22 | 0.625 | 0.8190311 | 723,255 | 0.0985 | 14.67% |
| 6 Months | 0.905 | 1.22 | 0.593 | 0.8020564 | 640,466 | -0.135 | -14.92% |
| 1 Year | 1.15 | 1.48 | 0.593 | 0.9681927 | 703,485 | -0.38 | -33.04% |
| 3 Years | 2.10 | 2.39 | 0.40 | 1.24 | 816,193 | -1.33 | -63.33% |
| 5 Years | 2.43 | 4.45 | 0.40 | 1.58 | 643,729 | -1.66 | -68.31% |
Cidara Therapeutics Description
| Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. |
